The Pharmacy Times® Pain Management resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, among other items that pharmacists will find valuable.
What can we help you find?
Migraines are a common condition, affecting about 38 million people in the United States and about 10% of people worldwide.
Why was a customer prescribed an allergy medication when she was expecting a pain pill?
Four case studies about skin and eye health.
Over-the-counter products featured in the May 2020 issue.
Amid differences in state programs, product labeling improvements must be adopted to protect patients.
In order to curb the opioid epidemic among employees, companies need to begin by identifying who is at risk.
Temptation exists because more than 90% of these patients are prescribed opioid medications for pain.
More than 53% of survey respondents reported having a diversion event within the last year, in addition to 37% who were aware of at least 1 colleague who has diverted controlled substances.
Researchers from the Mayo Clinic have found that inappropriate use of high-potency opioids has contributed to the opioid epidemic in the United States.
Why is this patient on oxybutynin if he does not have any problems with his bladder?
Cannabis products can counter some negative aspects of chemotherapy.
The FDA granted Amneal Pharmaceuticals for a generic version of buprenorphine (Butrans) transdermal system as well as a Competitive Generic Therapy designation.